Cross-Class Inhibition of the Cysteine Proteinases Cathepsins K, L, and S by the Serpin Squamous Cell Carcinoma Antigen 1: A Kinetic Analysis
- 21 March 1998
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 37 (15) , 5258-5266
- https://doi.org/10.1021/bi972521d
Abstract
The human squamous cell carcinoma antigens (SCCA) 1 and 2 are tandemly arrayed genes that encode two high-molecular-weight serine proteinase inhibitors (serpins). Although these proteins are 92% identical, differences in their reactive site loops suggest that they inhibit different types of proteinases. Our previous studies show that SCCA2 inhibits chymotrypsin-like serine proteinases [Schick et al. (1997) J. Biol. Chem. 272, 1849−1855]. We now show that, unlike SCCA2, SCCA1 lacks inhibitory activity against any of the more common types of serine proteinases but is a potent cross-class inhibitor of the archetypal lysosomal cysteine proteinases cathepsins K, L, and S. Kinetic analysis revealed that SCCA1 interacted with cathepsins K, L, and S at 1:1 stoichiometry and with second-order rate constants ≥ 1 × 105 M-1 s-1. These rate constants were comparable to those obtained with the prototypical physiological cysteine proteinase inhibitor, cystatin C. Also relative to cystatin C, SCCA1 was a more potent inhibitor of cathepsin K-mediated elastolytic activity by forming longer lived inhibitor−proteinase complexes. The t1/2 of SCCA1−cathepsin S complexes was >1155 min, whereas that of cystatin C−cathepsin complexes was 55 min. Cleavage between the Gly and Ser residues of the reactive site loop and detection of a stable SCCA1−cathepsin S complex by sodium dodecyl sulfate−polyacrylamide gel electrophoresis suggested that the serpin interacted with the cysteine proteinase in a manner similar to that observed for typical serpin−serine proteinase interactions. These data suggest that, contingent upon their reactive site loop sequences, mammalian serpins, in general, utilize their dynamic tertiary structure to trap proteinases from more than one mechanistic class and that SCCA1, in particular, may be involved in a novel inhibitory pathway aimed at regulating a powerful array of lysosomal cysteine proteinases.Keywords
This publication has 23 references indexed in Scilit:
- Squamous Cell Carcinoma Antigen 2 Is a Novel Serpin That Inhibits the Chymotrypsin-like Proteinases Cathepsin G and Mast Cell ChymaseJournal of Biological Chemistry, 1997
- Cellular Internalization and Degradation of Antithrombin III-Thrombin, Heparin Cofactor II-Thrombin, and α1-Antitrypsin-Trypsin Complexes Is Mediated by the Low Density Lipoprotein Receptor-related ProteinPublished by Elsevier ,1996
- Human Cathepsin O2, a Matrix Protein-degrading Cysteine Protease Expressed in OsteoclastsJournal of Biological Chemistry, 1996
- The Inhibition Mechanism of SerpinsPublished by Elsevier ,1995
- Serpin-Protease Complexes Are Trapped as Stable Acyl-Enzyme IntermediatesPublished by Elsevier ,1995
- Sodium Dodecyl Sulfate-stable Complexes between Serpins and Active or Inactive Proteinases Contain the Region COOH-terminal to the Reactive Site LoopPublished by Elsevier ,1995
- Squamous cell carcinoma antigen is a potent inhibitor of cysteine proteinase cathepsin LFEBS Letters, 1995
- Natural protein proteinase inhibitors and their interaction with proteinasesEuropean Journal of Biochemistry, 1992
- The basic difference in catalyses by serine and cysteine proteinases resides in charge stabilization in the transition stateJournal of Theoretical Biology, 1986
- Altered specificities of genetically engineered α1 antitrypsin variantsProtein Engineering, Design and Selection, 1986